Amgen agrees to develop biosimilars for Chinese market
Increasing its global footprint in the biosimilars market, Amgen announced Sept. 26 that it had formed an exclusive co-development agreement with Chinese drug manufacturer Simcere Pharmaceutical Group. The agreement aims to bring four oncology and inflammation biosimilars in Amgen’s portfolio to commercialization in China. The Thousand Oaks-based biotechnology company will produce and submit approval applications Read More →
Dole Food lays off another 400 berry workers
Westlake Village-based Dole Food continued to downsize its California berry operations with a layoff of more than 400 workers in Watsonville. The company submitted a notice to the California Employment Development Department at the end of August stating that the employees would be laid off effective Oct. 28. This comes after the announcement that 172 Read More →
PGA Tour Champions give Sherwood course high marks
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Innovation, pot will disrupt economy of Tri-Counties
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Frontier relocating to new facility in Thousand Oaks
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Managers need to develop social capital
By Kapp Johnson You might be well aware of John Donne’s poem “No Man is an Island.” Written in 1674, it was not originally a poem but prose. It speaks profoundly of what we might call social capital today. The poem speaks beyond networking to a depth of relationships that are more than instrumental. In Read More →
FDA approves Amgen cancer treatment biosimilar Mvasi
The U.S. Food and Drug Administration approved a cancer treatment biosimilar developed in partnership between Allergan and Thousand Oaks-based Amgen, the company announced Sept. 13. Mvasi was approved to treat five types of cancer in combination with other therapies. “The approval of Mvasi marks a significant milestone for healthcare practitioners and patients as the first Read More →
